tarlatamabMayo Clinic Rochestersmall cell lung cancerplatinum-based chemotherapyFDA
…n standard-of-care (SOC) practice.Methods Patients who received tarlatamab at Mayo Clinic Rochester consented to research blood. Immune ph…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 181–240 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Clarithromycin17Antibiotic17Anticoagulants17fludarabine17Inclisiran16Atropine16Secukinumab16Caffeine16Salbutamol16Ondansetron16Dapagliflozin16Naloxone16Methylene blue16Anakinra16Fluconazole16Rilpivirine16Analgesics16Rocuronium16Proton pump inhibitor16Osimertinib15Atogepant15ELAFIBRANOR15Pirfenidone15Dabigatran15Obinutuzumab15Rosuvastatin15Medicines15Amphotericin B15Ketorolac15Carbon Monoxide15ACE inhibitors15Phenylephrine15Glucocorticoid15non-steroidal anti-inflammatory drugs15Empagliflozin14Rimegepant14Fremanezumab14FeNO14Olaparib14GA14Relatlimab14IL-1214Lactulose14SpironolacTone14Mannitol14Levothyroxine14bleomycin14Sodium-glucose cotransporter 2 inhibitors14Beta Blockers14Axicabtagene Ciloleucel14adrenaline14Broad-spectrum antibiotics14Etoposide14Tenofovir14Intravenous Immunoglobulin14UPA13LMWH13Liposomal bupivacaine13Baricitinib13Ruxolitinib13
Articles mentioning drugs
10,506 articles · page 449 of 876IL-12IL-15breast cancerlung cancerimmunotherapy
…as selected for in vivo evaluation. In EMT6 tumor-bearing mice, IL-12/IL-15 combination therapy significantly suppressed tumor growth…
IO-HNP-mRNALPX-mRNAOva-mRNA
…ls. Female C57BL/6 mice received intravenous (IV) injections of IO-HNP-mRNA or LPX-mRNA, or intramuscular (IM) injections of LNP-mRNA, at d…
atezolizumabpembrolizumabdurvalumabmetastatic urothelial carcinomaEmory University
…ith multiple lines of immunotherapy (durvalumab, pembrolizumab, atezolizumab).Methods In our single-center retrospective cohort (n=57), prim…
CDK4/6 inhibitorsCDK 4/6 inhibitorsCDK4/6Breast cancerendocrine therapyXenoSTARTWorld Health Organization
…t, accounting for 2.3 million cases. 1 Despite advances such as CDK4/6 inhibitors in combination with endocrine therapy for hormone receptor-posi…
CDK4/6 inhibitorsCDK 4/6 inhibitorsCDK4/6breast cancerendocrine therapyXenoSTARTWorld Health Organization
…t, accounting for 2.3 million cases. 1 Despite advances such as CDK4/6 inhibitors in combination with endocrine therapy for hormone receptor-posi…
CB-1158Arg1Danish Animal Experimentation Council
…oid compartment, which was not observed with the Arg1 inhibitor CB-1158. Moreover, the anti-tumor activity was further enhanced by comb…
86.8%
ELI-004ELI-002cancerin situ immunotherapy
… by anchoring into cell membranes via its lipophilic AMP-tail.1 ELI-004 has been evaluated in multiple phase 1/2 trials (NCT04853017/NC…
azacitidinevenetoclaxacute myeloid leukemiaAML
…1b, HLA-DR) on AML cells both in vitro and in vivo. Compared to azacitidine as the benchmark hypomethylating agent, the intravenous injecti…
miraakhatOesophageal cancergastro-oesophageal reflux diseasepeptic ulcer diseasegastritisECGarissa County Referral HospitalPUDsurgery+1 more
…ors for EC, including tobacco use, hot tea consumption, chewing miraa, GERD, gastritis and PUD. Targeted screening of high-risk patie…
basal insulinbasal insulin-treatedT2Dtype 2 diabetesNCT03566693
…ic management in adults with type 2 diabetes (T2D) treated with basal insulin.Research design and methods Using data from the MOBILE study wh…